Overall rank by patents
#26,415
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 13 technology areas, active 2018–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME).
The verdict
Greenonyx holds 10 US patents across 13 technology areas, rank #26,415 of 50,000 tracked assignees.
Greenonyx Ltd has been granted 10 US utility patents between 2018 and 2023, placing Greenonyx Ltd at rank #26,415 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.7 claims per patent with primary concentration in C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME). As a Foreign Corporation, Greenonyx Ltd is one of the more focused assignees in the PatentsView dataset. By volume, Greenonyx sits between Grand General Accessories Manufacturing (10 patents, rank #26,411) and Groundspeak, Inc. (10 patents, rank #26,419) - the closest US assignees by grant volume. The composite Innovation Score of 39.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 4 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Greenonyx Ltd's 23.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Greenonyx Ltd against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Grand General Accessories Manufacturing
10 patents
Grand Valley State University
10 patents
Grasslanz Technology Limited
10 patents
Green Bay Packaging, Inc.
10 patents
Greyfin LLC
10 patents
Grifols Therapeutics Inc.
10 patents
Gritstone Bio, Inc.
10 patents
Groundspeak, Inc.
10 patents
GreenOnyx LTD
10 patents
What this shows Greenonyx holds 10 patents at rank #26,415, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Greenonyx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 20.0% |
| 2019 | 2 | 20.0% |
| 2020 | 2 | 20.0% |
| 2021 | 1 | 10.0% |
| 2023 | 3 | 30.0% |
Top 13 of 13 technology areas
Overall rank by patents
#26,415
Across all tracked assignees
39.3 out of 100
How to use this portfolio
Greenonyx's 10 grants land it in the top 39% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.